Compare McKesson Corporation (MCK) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs D Wave Quantum Inc — how do they compare? McKesson Corporation trades at $938.84 (market cap $108.46B), while D Wave Quantum Inc trades at $14.57 (market cap $5.54B). The key difference: McKesson Corporation is far larger — about 19.6× D Wave Quantum Inc's market cap, and McKesson Corporation pays a 0.4% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold McKesson Corporation for 74 Days and D Wave Quantum Inc for 32 Days on average.
| MCK | QBTS | |
|---|---|---|
Market Cap | $108.46B | $5.54B |
Volume | 712,607 | 16,671,452 |
Sector | Health | Technology |
52-Week High | $995.69 | $44.78 |
52-Week Low | $725.17 | $12.98 |
Typical Hold Time | 74 Days | 32 Days |
Enterprise Value | $115.00B | $5.04B |
Dividend Yield | 0.4% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
QBTS (D-Wave Quantum Inc.) trades at $14.60, down 4.07% on the day, amid a bearish technical signal and negative earnings trends. The company reported a net loss of $355.06 million on $24.59 million revenue for 2025, with a deeply negative net income margin. Despite 100% analyst buy ratings and a consensus price target of $34.38, the stock faces headwinds from multiple fraud investigations and cash burn, with operating cash flow negative $72 million in 2025.
The outlook is highly speculative; while analyst optimism and quantum computing potential offer upside, significant financial losses, legal risks, and bearish technicals present substantial downside. Investors should weigh the high-risk, high-reward profile carefully, as the company's path to profitability remains uncertain amid competitive and funding challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
